Delivery Order SPE2DB20D7059-SPE2DB26FGSE7
- Not listed
- The Defense Logistics Agency awarded a $1,557.76 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ramelteon 8 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,856.49 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with a contract ceiling value of $7,347.27. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The ultimate completion date is set for September 26, 2025, and the product will be delivered to AmerisourceBergen's location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $512 to Amerisourcebergen Drug Corporation. The order is for 4561773723, which is Ramelteon 8 mg tablets, with a quantity of 30 units. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 10-11, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA...
- The Defense Logistics Agency awarded a $596.88 delivery order to Amerisourcebergen Drug Corporation for the provision of 30 Ramelteon 8 mg tablets. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. The order is funded by the Defense Logistics Agency and has a period of performance spanning August 21, 2023 through August 22, 2023. No set...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $364.25 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 100 boxes of 8mg Ramelteon tablets to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will leverage its corporate infrastructure and distribution network based in Conshohocken, Pennsylvania to fulfill delivery of the pharmaceutical products to the customer by July 11,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,543.17 firm fixed price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGSE7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,431.92 for Ramelteon 8 mg tablets (30-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/6/25 |